# B Braun Melsungen Ag- Aktiengesellschaft – FDA Inspection, Jan 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/b-braun-melsungen-ag-aktiengesellschaft/c8bb478a-fefb-41a2-bc48-a187f39d2da3
Source feed: FDA_Inspections

> FDA inspection 1081920 of B Braun Melsungen Ag- Aktiengesellschaft, January 22, 2019. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081920
- Company Name: B Braun Melsungen Ag- Aktiengesellschaft
- Inspection Date: 2019-01-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1263340 - 2024-11-13](https://www.keypedia.com/records/fda_inspections/b-braun-melsungen-ag-aktiengesellschaft/ebc6e883-acb3-454e-9a36-8e38d7a123b8)
- [FDA Inspection 1025753 - 2017-08-29](https://www.keypedia.com/records/fda_inspections/b-braun-melsungen-ag-aktiengesellschaft/edce242f-9d32-44a8-9913-4724ff5a2625)
- FDA Inspection 884341 - 2014-05-20

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/b-braun-melsungen-ag-aktiengesellschaft/1a2b15e4-288a-426d-a9d6-7b7bbf698315

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c